Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- exagamglogene autotemcel
- Jadenu Sprinkle (deferasirox)
Interactions between your drugs
deferasirox exagamglogene autotemcel
Applies to: Jadenu Sprinkle (deferasirox), exagamglogene autotemcel
Before you can receive treatment with exagamglogene autotemcel, you will receive chemotherapy. Deferasirox may interfere with that chemotherapy treatment, so the makers of exagamglogene autotemcel suggest stopping deferasirox for a certain period of time before and after receiving treatment with exagamglogene autotemcel. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
deferasirox food
Applies to: Jadenu Sprinkle (deferasirox)
You may experience reduced absorption of deferasirox in the presence of food. Take deferasirox on an empty stomach 30 minutes before eating preferably at the same time everyday unless otherwise directed by your doctor. This will make it easier for your body to absorb the medication. The tablets should not be chewed or swallowed whole. The tablets should first be completely dispersed in water, orange juice, or apple juice, and the resulting suspension drunk immediately. After swallowing the suspension any residue should be resuspended in a small volume of the liquid and swallowed.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Reblozyl
Reblozyl is used to treat anemia in adults with beta-thalassemia or myelodysplastic syndromes ...
Zynteglo
Zynteglo (betibeglogene autotemcel) is a gene therapy indicated for the treatment of patients with ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Casgevy
Casgevy (exagamglogene autotemcel) is a gene therapy that is given as a one-time intravenous ...
Oxbryta
Oxbryta (voxelotor) is used for the treatment of patients with sickle cell disease (SCD). Oxbryta ...
Lyfgenia
Lyfgenia (lovotibeglogene autotemcel) is a gene therapy that uses a viral vector and is given as a ...
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Adakveo
Adakveo (crizanlizumab-tmca) is used for the prevention of vasoocclusive crises (VOCs) in patients ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.